Subscribe To Our Free Newsletter |
Jubilant Pharmova announces conclusion of Montreal facility audit by US FDA
Jubilant Pharmova said that the United States Food and Drug Administration (USFDA) has concluded audit of the Radiopharmaceutical manufacturing facility at Montreal, Canada.